ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ORMP Oramed Pharmaceuticals Inc

2.345
0.005 (0.21%)
Fuera de horario
Última actualización: 15:59:58
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Oramed Pharmaceuticals Inc ORMP NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.005 0.21% 2.345 15:59:58
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.31 2.24 2.375 2.345 2.34
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
19/3/202408:00GLOBEScilex Holding Company Announces Repayment in Full of the..
06/3/202416:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202407:42EDGAR2Form 8-K - Current report
20/2/202407:30PRNUSOramed Letter to Shareholders
30/1/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202415:45EDGAR2Form 8-K - Current report
19/1/202415:45EDGAR2Form 8-K - Current report
08/1/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202412:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/12/202308:26EDGAR2Form 8-K - Current report
18/12/202315:45EDGAR2Form 8-K - Current report
09/11/202316:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/9/202315:34EDGAR2Form 8-K - Current report
22/9/202310:38PRNUSSorrento Therapeutics, Inc. Announces the Consummation of..
21/9/202317:11PRNUSOramed Announces $101,875,000 Short-Term Senior Secured Note..
21/9/202315:05GLOBEScilex Holding Company Announces the Consummation of the..
13/9/202308:00GLOBEScilex Holding Company Enters into Non-Binding Term Sheets..
13/9/202307:47EDGAR2Form 8-K - Current report
10/8/202316:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202307:30EDGAR2Form 8-K - Current report
07/8/202308:20EDGAR2Form 8-K - Current report
02/8/202306:45PRNUSOramed Signs Term Sheet with HTIT to Create a Joint Venture..
13/7/202316:00EDGAR2Form 8-K - Current report
20/6/202306:55PRNUSOramed to Present at the 83rd American Diabetes Association..
18/5/202306:55PRNUSOramed to Present at Novel Therapies for Type 2 Diabetes &..
15/5/202308:05PRNUSOramed Announces that its Chinese Partner, HTIT, has..

Su Consulta Reciente

Delayed Upgrade Clock